NCT01474278View on ClinicalTrials.gov

A Study of RO5028442 in Adult Male High-Functioning Autistic Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Autistic Disorder
Interventions
DRUG

Placebo

Single dose

DRUG

RO5028442

Single dose

Trial Locations (3)

10467

The Bronx

90095

Los Ageles

06510

New Haven

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01474278 - A Study of RO5028442 in Adult Male High-Functioning Autistic Patients | Biotech Hunter | Biotech Hunter